Specific antagonists were given 2 h before glucose at 1,500 nmol kg 1 doses, and tirzepatide was given 1 h before glucose, all by intraperitoneal injection
Imbalanced redox states are increasingly recognized as underlying factors in major diseases, including cancers, neurodegenerative conditions, heart disease, and metabolic disorders [113]
More people need treatment for obesity: The rise in obesity rates parallels the rise in GLP-1 prescriptions
Could once-daily therapy replace twice-daily dosing
Pregnant or breastfeeding individuals Inositol has been studied during pregnancy (especially for gestational diabetes prevention), and meta-analyses have not identified major safety concerns at typical study doses.24 45 Even so, pregnancy and breastfeeding are situations where supplementation should be individualized, so its best to consult a healthcare provider before starting inositol.26 People prone to gastrointestinal upset Overall, inositol has a strong safety profile, especially when used within the 24g per day range most commonly studied in human trials.12 13 Who are inositol supplements for